Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
New Strong Buy Stocks for March 13th
09:11am, Wednesday, 13'th Mar 2024
SBSI, EBMT, LMAT, ANF and FHI have been added to the Zacks Rank #1 (Strong Buy) List on March 13, 2024.
39 Upcoming Dividend Increases Including 2 Dividend Kings
11:48am, Friday, 08'th Mar 2024
Thirty-nine companies, including Coca-Cola and Telephone and Data Systems, are raising their dividends.
Best Momentum Stocks to Buy for March 7th
11:01am, Thursday, 07'th Mar 2024
TOL, WILYY and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 7, 2023.
LeMaitre Vascular (LMAT) is a Great Momentum Stock: Should You Buy?
01:01pm, Tuesday, 05'th Mar 2024
Does LeMaitre Vascular (LMAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Best Momentum Stocks to Buy for March 5th
11:01am, Tuesday, 05'th Mar 2024
LMAT, SPXC and BBVA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 5, 2023.
LeMaitre to Participate at Upcoming Investor Conferences in March
04:37pm, Friday, 01'st Mar 2024
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre (LMAT) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Thursday, 29'th Feb 2024
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
10:59pm, Tuesday, 27'th Feb 2024
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
LeMaitre Q4 2023 Financial Results
04:05pm, Tuesday, 27'th Feb 2024
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2023 results, announced a $0.16/share quarterly di
MDT vs. LMAT: Which Stock Should Value Investors Buy Now?
12:46pm, Wednesday, 21'st Feb 2024
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang fo
LeMaitre Vascular (LMAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Tuesday, 20'th Feb 2024
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024
10:37am, Tuesday, 13'th Feb 2024
BURLINGTON, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024,
LeMaitre to Present at the 26th Annual Needham Growth Conference
02:31pm, Thursday, 11'th Jan 2024
BURLINGTON, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 26th Annual Needha
ESLOY or LMAT: Which Is the Better Value Stock Right Now?
12:47pm, Tuesday, 05'th Dec 2023
Investors interested in Medical - Products stocks are likely familiar with EssilorLuxottica Unsponsored ADR (ESLOY) and LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to va
How Much Upside is Left in LeMaitre (LMAT)? Wall Street Analysts Think 25.24%
11:16am, Friday, 10'th Nov 2023
The consensus price target hints at a 25.2% upside potential for LeMaitre (LMAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
